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INTRODUCTION 
Down syndrome common chromosomal disorder, relat-
ed with multiple congenital anomalies with mental re-
tardation in the new borns. Incidence of Down syn-
drome varies from 1 in 600 to 1 in1000 in live born in-
fants [1, 2]. In India, incidence of Down syndrome is 1 
in 1250 [1].  
By the Cytogenetic Analysis the presence of the extra 
21 in DS has been classified free Trisomy 21, transloca-
tion trisomy21 and mosaic trisomy 21 [3]. Free trisomy 
21 is the most common variety, seen in 95% cases and 
occurs due to paternal meiotic non disjunction [1]. 2 
to4% showed a Robertsonian translocation and 1to 3% 
showed mosaicism. 
The clinical features are important for an early diagnosis 
to reduce morbidity and mortality. Apart from karyo-
type most characteristic features are mental retardation, 
congenital heart defects, facial features and in some 
cases developing AML at later stage [4].  
The oral motor approached activities are effective in 
enhancing the feeding performance among children with 
Down’s syndrome. It was also found that the therapy 
protocol has a greater effect in reducing tongue thrust 
thereby improving oral functional skills [5]. 
The extra chromosome 21 is translocated to the acrocen-
tric chromosome of D group (Chromosome 13, 14, 15) 
or G group (Chromosome 21, 22). Such translocations 
are usually Robertsonian in type [1]. Non homologous 
Robertsonian translocation between chromosome 14 
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and 21 [rob (14q; 21q)] is the most common type while 
homologous Robertsonian translocation between chro-
mosome 21 and 21[rob(21q;21q)] is the second most 
common type[6].Translocation Down Syndrome can be 
inherited from carrier parents [7].  
Down syndrome occurs in people of all races and eco-
nomic levels, though older women have an increased 
chance of having a child with Down syndrome. A 35 
year old woman has about a one in 350 chance of con-
ceiving a child with Down syndrome, and this chance 
increases gradually to 1 in 100 by age 40. At age 45 the 
incidence becomes approximately 1 in 30. The age of 
the mother does not seem to be linked to the risk of 
translocation. To study the effect of advanced maternal 
age on Down syndrome many hypotheses have been 
formulated. Initially Penrose identified that advanced 
maternal age as risk for Down syndrome birth [8]. 
The relation of advanced maternal age to an increased 
risk of DS has been well documented. In addition, ma-
ternal risk other than maternal age for DS births is clear-
ly includes genetic and other risk factors in few pub-
lished studies. With regard to genetic factor, Coppode et 
al. [9] has studied the role of methionine synthase re-
ductase (MTRR), G-polymorphism as maternal risk 
factor for birth of DS in Caucasian women. Genetic 
polymorphism of MTHFR C677T, MTHFR A1298C in 
association with serum and RBC folate and serum ho-
mocysteine on maternal risk factor of Down syndrome
[10]. On the other hand, Shalaby [11] explained other 
risk factors such as consanguinity, drug and environ-
mental toxins and reproductive functions for increase 
incidences of DS. Karyotyping analysis were used in 
both human & Plant cells to determine the structural 
changes in chromosomes [12].By the Karyotyping anal-
ysis chromosomal rearrangements can be seen in Infer-
tility cases [13].  
North Karnataka with its unique culture, customs and 
socio demographic factors is conductive to the occur-
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rence of different genetic disorders including population 
growth, demographic pattern, occupational shifts with 
high proportion of individuals engaged in sedentary 
lifestyle and substantially higher proportion of pre-
obese and obese individuals. Consanguineous marriage 
is a traditional practice in many communities around the 
world. By keeping these points, in this study an attempt 
was made to trace out the role of in Down syndrome in 
north Karnataka population through Karyotyping Anal-
ysis. 
MATERIALS AND METHODS 
Study design: An observational descriptive study 
Ethics approval: Study was approved by the institu-
tional ethics committee and informed consent was taken 
from the parents. 
Study location: Genetics laboratory, department of 
Anatomy, BLDE (DU), Karnataka  
Study period: The study was carried from June 2016 to 
January 2017. 
Inclusion criteria: All the participants were taken from 
our hospital, children’s of age 0-5 years. Down Syn-
drome cases were recruited in our study . 
Exclusion criteria: Other congenital defects and CHD 
cases as well as patients from other hospitals were ex-
cluded from the study. 
Sample size: The present study subjected total of Twen-
ty eight pediatric patients, with the age group of 3 to 
120 days old out of which 12were female and 16 were 
male.[4] 
Methodology:  
For Cytogenetic analysis we collected 1 ml peripheral 
blood samples from Out Patient Pediatric department. 
Karyotyping was carried out for peripheral lympho-
cytes, cultured from peripheral blood and stained with 
Giemsa stain as per the Standard Operating Protocol. 
Olympus Trinocular Research Florescent In Situ Hy-
bridization (FISH) with Applied Spectral Imaging Kary-
otyping System (Manufacturer name: Olympus, Japan; 
model: CH20i) was also used during the study. 20-40 
spreads were analyzed for each case. The slides were 
analyzed for detection of chromosomal abnormality for 
Down syndrome (Trisomy 21).  
RESULTS   
A total of 28 clinically suspected cases were referred to 
our genetics laboratory for cytogenetic analysis. Of 
which 5 cases were found confirmed DS. The rest 
23cases were found to be other chromosomal anomalies. 
The maternal age of mother of DS patients are not ad-
vanced as shown I n (Table 1).The age of all DS pa-
tients were calculated and it was found to be 3days to 4 
months as shown in (Table2). Descriptive Statistics 
shows age mother with age DS patients in terms of 
standard deviation mother age will be 0.64 & patients 
will be 24.6 (Table 3). Proportion rate of Down syn-
drome is 18%, other syndrome will be 82 % 
(Table4).All these cases were found to be free trisomy 
form (Figure 1). 
 
Table 1. Distribution of patients according to Age of 
mothers 
 
Table 2. Distribution of patients according to Age of 
Infants 
 
Table 3. Descriptive Statistics. 
 
Table 4. Proportion of Down syndrome 
 
Figure 1. Down syndrome with free 21 normal tri-




24 1 3.6 
25 13 46.4 
26 13 46.4 
27 1 3.6 
Total 28 100.0 
Days Frequency Percent 
7 10 36 
8-14 6 21 







Total 28 100.0 
Age N Minimum Max Mean 
Age of 
Mothers 
28 24 27 25.5±0.64 
Age of 
infants 
28 3 120 20.7±24.6 
Diagnosis N Percentage 
Down Syndrome 5 18 
Other  Syndrome 23 82 
Total 28 100 
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Down syndrome has a prevalence of one in 500 to one 
in 1,000 live births, due to disorder of development aris-
ing from incomplete embryogenesis as a result of an 
additional chromosome 21 copy in the karyotype. This 
extra chromosome is derived from an over-expression 
of genetic material due to a tripling of the number of 
genes. This phenomenon produces structural and func-
tional disorders of the all the systems of the body [14]. 
There are three forms of DS namely simple trisomy, 
Mosaic trisomy and translocation trisomy.  Karyotype 
analysis of our study finds only the simple trisomy, in 
which a form of faulty division of reproductive cell 
(generally occurring during 1st or 2nd meiotic division) 
prior to or at conception that results in an embryo with 
three copies of chromosome 21. As the embryo devel-
ops, the extra chromosome is replicated in every cell of 
the body. The parental and the meiotic/mitotic origin of 
the additional chromosome 21 could be determined in 
the early 1990’s with the help of DNA markers [15].  
Simple Trisomy 21 in fact constitutes the most common 
form of DS in children and occurs at rates of 90-95%. 
Karyotype for female are 47, XX, +21 and 47, XY, +21 
for male [15]. 
Translocation involves transferring a chromosome frag-
ment to centromere of another acrocentric chromosome. 
In DS such translocation occurs between chromosomes 
14 and 21 which occur at rates of 5-6% of all DS cases. 
The karyotype for female are 46, XX, der (21;21), +21 
or 46, XX, der (14;21), +21 and for male 46, XY, der 
(21;21), +21 or 46, XY, der (14;21), +21[15]. 
A seldom form of DS is a condition known as mosai-
cism, which accounts for only 1-2% of all cases of full 
trisomy 21 DS Mosaicism characterized by the non-
disjunction of chromosome 21 takes place in one of the 
initial cell divisions after fertilization, resulting in a 
mixture of two types of cells in the body, some with 46 
and some with 47 chromosomes. The physical features 
of Down’s may be milder in individuals with mosaicism 
trisomy 21, especially if the proportion of normal cells 
is large [16]. All diagnosed cases were reported in our 
study were having confirmed DS in north Karnataka 
region. The frequency of free trisomy reported in the 
present study is most common seen which is in accord-
ance with earlier reports [17, 18, 19]. Other studies re-
vealed that advanced paternal age combined with ad-
vanced maternal age significantly influences the inci-
dences of DS [20].However, earlier studies in the world 
reports regarding the maternal and paternal ages that 
increases the risk of chromosomal aneuploidy [21]. Pre-
sent study shows that the overall female ratio was more 
compared to male. Other studies reported that excess of 
males appears to be universal and reported in literature 
from all over the world. Present study Translocation 
trisomy21 & mosaic 21were not observed. Transloca-
tion and mosaic which are unique in nature as compared 
to previous studies [18].  
There were reports of older maternal age having DS in 
previous studies from different countries [22, 23]. On 
the other hand, few studies have also reported incidenc-
es of DS to a much young maternal age [17, 24].In our 
study revealed that incidences of DS is young maternal 
age. 
Several studies have been done on incidence of DS, but 
a complete understanding of the cause is yet to be ascer-
tained. Risk factors of DS unlike maternal age, recently 
Coppode et al. [9] have suggested folate polymorphism 
as genetic risk factor for birth of DS child in Caucasian 
women and Shalaby [11] reported consanguinity, drug 
and environmental toxins as other risk factors. 
CONCLUSION 
In the Present study Genetic factors & maternal age are 
higher incidences in Down syndrome. In the present 
study conclude that free trisomy 21 is most common 
type Down syndrome chromosomal abnormality in this 
region.  
Suggestions: It is important to educate & create aware-
ness to family at high risk occurrence to go for screen-
ing during pregnancy. It is necessary to adopt appropri-
ate prevention strategies and interventions in high risk 
individuals to curb the growing epidemic of Down syn-
drome. Innovative community outreach programmes 
need to be designed and implemented for creating 
awareness, early screening and treatment of Down syn-
drome. 
Limitation of study: India is known for high degree of 
inbreeding with its heterogynous population. This 
makes it necessary to screen a large number of patients 
perhaps within each group in order to get a true picture 
of Down syndrome. In order to find out the prevalence 
of any risk factors, a large number of families need to be 
investigated 
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